We urge you to utilize analysis of Digirad fundamentals to see if markets are presently mispricing the company. We found thirty-seven available fundamental indicators for Digirad Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Digirad fundamentals including its Shares Outstanding, Price to Sales, Cash per Share, as well as the relationship between Number of Shares Shorted and EBITDA . Please also check Digirad Corporation Price to Earning to verify the company can sustain itself down the road.Use Digirad to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Digirad to be traded at $2.76 in 30 days
Digirad Valuation Over Time
Digirad Company SummaryDigirad competes with Edwards Lifesciences, DarioHealth Corp. Digirad Corporation provides healthcare solutions in the United States. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Digirad operates under Medical Appliances Equipment classification in USA and traded on NASDAQ General Markets exchange. It employs 507 people.
Digirad Retained Earnings vs Gross Profit
Digirad Corporation is rated # 3 in retained earnings category among related companies. It is rated # 2 in gross profit category among related companies .